Trial NCT00240162

View at ClinicalTrials.gov 
Org. Study IDs: 05-0639
Secondary IDs: IND#: 72,721

Last trial update was posted on 2014-09-17

MeSH Interventions

Vatalanib

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

investigator letter from drug manufacturer stating animal studies showed increased risk of cancer which was an unknown adverse event

Limitations And Caveats

In November 2008, it was reported that the drug might have carcinogenic potential in animal models. At that time, the remaining three patients were taken off study.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID